PULIKE BIOLOGICAL revenue breakdown overview

PULIKE BIOLOGICAL revenue for the last year amounted to 1.04 B CNY, the most of which — 429.39 M CNY — came from its highest performing source at the moment, Poultry Vaccines and Antibodies, the year earlier bringing 415.63 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought PULIKE BIOLOGICAL 1.01 B CNY, and the year before that — 1.23 B CNY.